What’s News, Breaking: Thursday, February 22, 2024
NY ATTORNEY GENERAL: SINGULAR CAUSES
DANGEROUS BEHAVIORAL CHANGES IN CHILDREN
NATIONWIDE — THE WELL-KNOWN ASTHMA AND ALLERGY DRUG MONTELUKAST, KNOWN BY ITS BRAND NAME SINGULAIR, has come under fire from New York Attorney General Letitia James. This week, she called on the US Food and Drug Administration to implement newer and stronger safety regulations over montelukast/Singulair, citing the drug’s dangers to mental and behavioral health. The Office of the Attorney General pointed out that Singulair has been linked to harmful behavioral and mental health issues among children who use it to treat asthma and respiratory allergies. Among these risks were increased cases of aggression, depression and suicide that parents observed in their children.
Attorney General James asserts that the FDA must remedy this lack of specific warning, restriction or contraindications regarding dangerous and potentially deadly side effects for pediatric patients to prioritize more sufficient warnings